US Patent 9486521 Therapeutic applications targeting SARM1
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+232 characters)
Article
Patent abstract
The present disclosure provides methods for reducing axonal and/or synaptic degradation in neurons by modulating sterile α/Armadillo/Toll-Interleukin receptor homology domain protein (SARM) activity and/or expression.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Marc Freeman0
Stephan Zuchner0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09486521 Therapeutic applications targeting SARM1 US Patent 9486521 Therapeutic applications targeting SARM1
Infobox
Patent Number
094865210
Patent Number
94865210
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
094865210
Date of Patent
November 8, 2016
0Patent Application Number
140872060
Date Filed
November 22, 2013
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09486521 Therapeutic applications targeting SARM1
Infobox
Is a
Patent jurisdiction
Patent number
09486521
Date of patent
November 8, 2016
Patent application number
14087206
Date Filed
November 22, 2013
Patent primary examiner
Find more entities like US Patent 9486521 Therapeutic applications targeting SARM1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
